MarketPeel
Insider Trading Intelligence
Pricing
…
SR

Scott M. Rocklage

IDYA
10% OWNER · IDEAYA BIOSCIENCES, INC. · CIK 0001219014
FILING MIX · LIFETIME17%/83%
BUYS
10
SELLS
50
TOTAL VALUE
$96.33M
COMPANIES
6
ACTIVE SINCE
May 2020
HOLDINGS NOW
7,653,640
AVG SELL PX
$14.49
TRADE KIND
SHOWING 60 / 60
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
40 backtested trades · 8 horizons · 26 pending
Forward-return performance of every backtestable P/S trade by Scott M. Rocklage, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d40+62.50%-6.06%+0.57%-6.63%-0.92%-2.52
14d40+65.00%-9.74%+0.92%-10.66%-11.75%-3.06
30d40+77.50%-4.32%+1.90%-6.22%-17.12%-0.72
60d40+80.00%-11.30%+4.51%-15.81%-22.07%-2.05
90d40+80.00%-15.19%+5.73%-20.92%-26.26%-2.55
180d40+67.50%-24.84%+7.82%-32.66%-53.75%-4.38
1y40(7 pending)+63.64%-27.77%+16.98%-44.75%-50.17%-6.13
2y40(19 pending)+57.14%-42.23%+17.48%-59.72%-72.20%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IDYA · 384,496 shares · as of Nov 11, 2020
0546,8571,093,7141,640,5712,187,428SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 10 buys / 50 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
200,000$8.80$1.76M2,963,066Nov 14, 2025Nov 18, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
163,979$3.42$560.8K1,457,064Aug 22, 2025Aug 22, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
6,470$3.42$22.1K57,493Aug 22, 2025Aug 22, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
2,314$3.57$8.3K63,963Aug 21, 2025Aug 22, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
58,642$3.57$209.4K1,621,043Aug 21, 2025Aug 22, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,935$7.50$52.0K1,093,313Jul 9, 2025Jul 11, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
20,065$7.50$150.5K3,163,066Jul 9, 2025Jul 11, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,422$7.12$45.7K1,100,248Jul 1, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
18,578$7.12$132.3K3,183,131Jul 1, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,422$6.81$43.8K1,106,670Jun 30, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
18,578$6.81$126.6K3,201,709Jun 30, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
55,735$6.91$385.1K3,220,287Jun 27, 2025Jul 1, 2025 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
19,265$6.91$133.1K1,113,092Jun 27, 2025Jul 1, 2025 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
2,000$6.06$12.1K1,679,685Sep 13, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
11,758$6.06$71.3K8,167,206Sep 13, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
79$6.06$47966,277Sep 13, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
1,440$6.60$9.5K66,356Sep 11, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
36,504$6.60$240.9K1,681,685Sep 11, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
214,556$6.60$1.42M8,178,964Sep 11, 2024Sep 13, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASE
450,000$10.00$4.50M8,393,520Mar 13, 2024Mar 15, 2024 ↗View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASE
5,206,074$2.31$12.03M7,943,520Jan 31, 2024Feb 2, 2024 ↗View →
RLYB
RALLYBIO CORP
SALE
100,000$8.20$820.0K2,378,969Mar 7, 2023Mar 9, 2023 ↗View →
RLYB
RALLYBIO CORP
SALE
99,671$12.50$1.25M2,478,969Jun 3, 2022Jun 7, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
50,329$12.50$629.1K1,251,755Jun 3, 2022Jun 7, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
33,553$13.00$436.2K1,302,084May 23, 2022May 25, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
66,447$13.00$863.8K2,578,640May 23, 2022May 25, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
139,539$13.05$1.82M2,645,087Feb 8, 2022Feb 10, 2022 ↗View →
RLYB
RALLYBIO CORP
SALE
70,461$13.05$919.5K1,335,637Feb 8, 2022Feb 10, 2022 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
318,140——882,357Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
564,217——564,217Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
318,616——649,771Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
250,000$20.00$5.00M1,132,357Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
2,371,739——3,021,510Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
254,512——3,276,022Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
2,302,026——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
4,082,613——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
17,161,644——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
2,305,473——0Nov 2, 2021Nov 4, 2021 ↗View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
1,841,620——0Nov 2, 2021Nov 4, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
36,544$13.00$475.1K333,144Nov 1, 2021Nov 3, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
258,456$13.00$3.36M1,731,119Nov 1, 2021Nov 3, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
625,000$9.70$6.06M1,989,575Sep 7, 2021Sep 9, 2021 ↗View →
RLYB
RALLYBIO CORP
PURCHASE
615,384$13.00$8.00M1,406,098Aug 2, 2021Aug 4, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
10,530$13.00$136.9K369,688Jan 12, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
74,470$13.00$968.1K2,614,575Jan 12, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
264,589$13.00$3.44M2,689,045Jan 8, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
37,411$13.00$486.3K380,218Jan 8, 2021Jan 12, 2021 ↗View →
CABA
CABALETTA BIO, INC.
SALE
261,084$14.75$3.85M2,953,634Dec 10, 2020Dec 14, 2020 ↗View →
CABA
CABALETTA BIO, INC.
SALE
36,916$14.75$544.5K417,629Dec 10, 2020Dec 14, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
27,379$13.66$374.0K91,142Nov 11, 2020Nov 13, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
657,117$13.66$8.98M2,187,428Nov 11, 2020Nov 13, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
115,504$13.66$1.58M384,496Nov 11, 2020Nov 13, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
175,000$25.30$4.43M138,497Oct 5, 2020Oct 7, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,600——5,600Jun 30, 2020Jul 1, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
4,807$33.30$160.1K75,965Jun 16, 2020Jun 18, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
115,357$33.30$3.84M1,823,192Jun 16, 2020Jun 18, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
235,200$28.75$6.76M1,938,549Jun 11, 2020Jun 15, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
9,800$28.75$281.8K80,772Jun 11, 2020Jun 15, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
10,200$35.15$358.5K90,572May 19, 2020May 21, 2020 ↗View →
APRE
APREA THERAPEUTICS, INC.
SALE
244,800$35.15$8.60M2,173,748May 19, 2020May 21, 2020 ↗View →
Other insiders · IDYA
Loading peer insiders…
About this filer
CIK 0001219014
ROLE
10% Owner
PRIMARY
IDYA
COMPANIES
6
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001219014DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback